<div id="readability-page-1"><div><p>As the U.S. stock market continues to reach new heights, with the S&amp;P 500 closing at a record high after a series of positive economic indicators, investors are keenly observing the landscape for promising opportunities. In this vibrant market environment, identifying undiscovered gems among small-cap stocks can offer unique growth potential, especially as these companies often thrive in periods of robust economic expansion and increased consumer spending.</p><h3>Top 10 Undiscovered Gems With Strong Fundamentals In The United States</h3><table><tbody><tr><th>Name</th><th>Debt To Equity</th><th>Revenue Growth</th><th>Earnings Growth</th><th>Health Rating</th></tr><tr><td>First Bancorp</td><td>57.63%</td><td>1.47%</td><td>-2.43%</td><td>★★★★★★</td></tr><tr><td>Oakworth Capital</td><td>40.91%</td><td>15.96%</td><td>11.47%</td><td>★★★★★★</td></tr><tr><td>Sound Financial Bancorp</td><td>34.24%</td><td>1.40%</td><td>-12.55%</td><td>★★★★★★</td></tr><tr><td>Franklin Financial Services</td><td>127.01%</td><td>5.48%</td><td>-4.56%</td><td>★★★★★★</td></tr><tr><td>Epsilon Energy</td><td>NA</td><td>2.43%</td><td>-4.36%</td><td>★★★★★★</td></tr><tr><td>Metalpha Technology Holding</td><td>NA</td><td>75.66%</td><td>28.60%</td><td>★★★★★★</td></tr><tr><td>ASA Gold and Precious Metals</td><td>NA</td><td>13.18%</td><td>16.77%</td><td>★★★★★☆</td></tr><tr><td>Seneca Foods</td><td>41.64%</td><td>2.31%</td><td>-23.77%</td><td>★★★★★☆</td></tr><tr><td>NameSilo Technologies</td><td>12.63%</td><td>14.48%</td><td>3.12%</td><td>★★★★★☆</td></tr><tr><td>Union Bankshares</td><td>369.65%</td><td>1.12%</td><td>-7.45%</td><td>★★★★☆☆</td></tr></tbody></table><p> Click here to see the full list of 298 stocks from our US Undiscovered Gems With Strong Fundamentals screener.     </p><p>We're going to check out a few of the best picks from our screener tool.</p><h2>Ituran Location and Control (ITRN)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Ituran Location and Control Ltd. offers location-based telematics services and machine-to-machine telematics products across Israel, Brazil, and other international markets, with a market cap of approximately $859 million.</p><p><strong>Operations:</strong> The company generates revenue through its telematics services and products, with telematics services contributing $255.03 million and telematics products adding $93.38 million. The net profit margin is a key financial metric to consider when evaluating the company's profitability.</p><p>Ituran Location and Control, a nimble player in the market, has seen earnings grow at an impressive 22.9% annually over the past five years. Despite being debt-free now compared to a 48% debt-to-equity ratio five years ago, its earnings growth of 9.1% last year lagged behind the Communications industry average of 43.3%. Recently, Ituran signed a promising three-year service agreement with Renault for Latin America, potentially expanding globally. The company also announced a $0.50 per share dividend and completed repurchasing shares worth $22.32 million since August 2021, signaling confidence in its financial health and future prospects.</p><ul><li>Delve into the full analysis health report here for a deeper understanding of Ituran Location and Control.</li><li>Assess Ituran Location and Control's past performance with our detailed historical performance reports.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/75f0d693-0b25-4d73-976f-0db2ca6fd5cd/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/75f0d693-0b25-4d73-976f-0db2ca6fd5cd/chart/earnings-and-revenue-growth"/><figcaption>ITRN Earnings and Revenue Growth as at Dec 2025</figcaption></figure><h2>Puma Biotechnology (PBYI)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> Puma Biotechnology, Inc. is a biopharmaceutical company that develops and commercializes products aimed at enhancing cancer care in the United States and internationally, with a market capitalization of $297.81 million.</p><p><strong>Operations:</strong> Puma Biotechnology generates revenue primarily from the development and commercialization of innovative cancer care products, totaling $212 million. The company's financial performance is influenced by its ability to manage costs associated with product development and marketing.</p><p>Puma Biotechnology, a player in cancer treatment, is navigating through some rough waters with its financials. The company reported third-quarter revenue of US$54 million, down from US$80 million the previous year, while net income fell to US$8.84 million from US$20.3 million. Despite these setbacks, Puma's earnings growth over the past year at 59% outpaced the broader Biotech industry at 56%. With EBIT covering interest payments 8.8 times over and more cash than debt on hand, Puma seems financially stable for now. However, significant insider selling and projected revenue declines suggest caution moving forward.</p><ul><li>Puma Biotechnology's future hinges on diversifying revenue beyond its sole product, NERLYNX. Click here to explore the full narrative on Puma Biotechnology's strategic outlook.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0fd7d9d1-2dab-4a3d-a440-96c46ba6ce7d/chart/debt-equity-history-analysis"/><figcaption>PBYI Debt to Equity as at Dec 2025</figcaption></figure><h2>SandRidge Energy (SD)</h2><p><strong>Simply Wall St Value Rating:</strong> ★★★★★★</p><p><strong>Overview:</strong> SandRidge Energy, Inc. operates in the acquisition, development, and production of oil, natural gas, and natural gas liquids primarily in the U.S. Mid-Continent region with a market cap of $525.84 million.</p><p><strong>Operations:</strong> Revenue from the acquisition, development, and production of oil, natural gas, and natural gas liquids amounted to $155.93 million.</p><p>SandRidge Energy has been making waves in the energy sector with its robust performance. The company's earnings surged by 40% over the past year, outpacing the Oil and Gas industry's -16% performance. Operating without debt, SandRidge's financial health is underscored by a Price-To-Earnings ratio of 8x, which is significantly lower than the US market average of 19x. Recent production results show a notable increase in oil output, up 49% year-over-year for Q3 2025, contributing to revenue growth from US$30 million to US$39.82 million compared to last year. Additionally, their strategic buyback initiative saw repurchase of shares worth $6.69 million underlining shareholder value focus.</p><ul><li>Take a closer look at SandRidge Energy's potential here in our health report.</li><li>Learn about SandRidge Energy's  historical performance.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f53e06e7-f70a-4210-923b-78c3d1727bec/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/f53e06e7-f70a-4210-923b-78c3d1727bec/chart/earnings-and-revenue-growth"/><figcaption>SD Earnings and Revenue Growth as at Dec 2025</figcaption></figure><h2>Next Steps</h2><ul><li>Embark on your investment journey to our 298 US Undiscovered Gems With Strong Fundamentals selection here.</li><li>Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive.</li><li>Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.</li></ul><h2>Looking For Alternative Opportunities?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li><li>Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><p>Mobile Infrastructure for Defense and Disaster</p><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p><p>Get the investor briefing before the next round of contracts</p><p><span>Sponsored On Behalf of CiTech</span></p></div></div></div>

<p>The U.S. stock market is reaching new heights, prompting investors to explore small-cap stocks with strong fundamentals for growth potential. Highlighted companies include First Bancorp, Oakworth Capital, and SandRidge Energy, among others. Ituran Location and Control and Puma Biotechnology are noted for their strategic moves and financial health. SandRidge Energy shows robust performance in the energy sector. Investors are encouraged to explore these undiscovered gems for promising opportunities.</p>

US Market's Undiscovered Gems to Explore This December 2025